Position in MRNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,612,331
+$6,443,881 QoQ
Shares Held
108,701
+372.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#114
of 772 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Jun 30, 2026CallValue
$10,399,455
CallShares
148,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Militia Capital Management LLC holds $38,661,383 across 19 Biotechnology names. MRNA ranks #1 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
108,701 | $7,612,331 | |
| 2 | NKTR |
Nektar Therapeutics
|
90,000 | $6,282,900 | |
| 3 | CYTK |
Cytokinetics Inc
|
60,000 | $5,111,400 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
20,000 | $3,745,600 | |
| 5 | INSM |
INSMED Inc
|
35,100 | $3,742,362 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
166,600 | $2,968,812 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,000 | $2,494,160 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
33,900 | $1,925,859 |
All Filings in MRNA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,399,455 | 148,500 | Call | Sole | 2026-08-12 | |
| 2026-06-30 | $7,612,331 | 108,701 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,168,450 | 23,001 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||